{
    "uniprot_canonical_ac": "A0A0B4KI34-1",
    "uniprot_id": [
        {
            "id": "A0A0B4KI34_DROME",
            "url": "https://www.uniprot.org/uniprot/A0A0B4KI34_DROME",
            "type": "external"
        }
    ],
    "mass": 98521.0,
    "length": 941,
    "protein_name": "CIN85 and CD2AP related, isoform J",
    "gene_name": "cindr",
    "organism": "Fruit fly",
    "refseq_name": "CIN85 and CD2AP related, isoform J",
    "refseq_ac": [
        {
            "id": "NP_001263129",
            "url": "https://www.ncbi.nlm.nih.gov/protein/NP_001263129",
            "type": "external"
        }
    ],
    "gene_names_uniprotkb": "cindr; BcDNA.GH03163; BcDNA:GH03163; CD2AP; CG11316; CG1408; CG31012; Cindir; Cindr; Dmel\\CG31012; Dmel_CG31012",
    "gene_names_refseq": "BcDNA:GH03163; CD2AP; CG11316; CG1408; CG31012; Cindir; Cindr; Dmel\\CG31012; cindr",
    "protein_names_uniprotkb": "CIN85 and CD2AP related, isoform J",
    "protein_names_refseq": "CG31012-PJ; cindr-PJ; CD2AP and CIN85 orthologue; CIN85 and CD2AP orthologue; CIN85 and CD2AP related, isoform J",
    "tax_id": 7227,
    "disease": "immunodeficiency 61 (Disease Ontology:DOID:0111999); focal segmental glomerulosclerosis 3 (Disease Ontology:DOID:0112245); nephrotic syndrome (Disease Ontology:DOID:1184); focal segmental glomerulosclerosis (Disease Ontology:DOID:1312); tauopathy (Disease Ontology:DOID:680); end stage renal disease (Disease Ontology:DOID:783)",
    "pathway": " (dme:Dmel_CG31012);  (R-DME-182971);  (R-DME-8856825);  (R-DME-8856828)",
    "pathway_count": 4,
    "publication_count": 12,
    "publication_id_list": "10731132;12537568;12537572;12537573;12537574;16110336;17569856;17569867;25589440;26109356;26109357;33925313",
    "function": "",
    "predicted_glycosites": 0,
    "predicted_n_glycosites": 0,
    "predicted_o_glycosites": 0,
    "mined_glycosites": 0,
    "mined_n_glycosites": 0,
    "mined_o_glycosites": 0,
    "reported_n_glycosites": 0,
    "reported_o_glycosites": 0,
    "reported_n_glycosites_with_glycan": 0,
    "reported_o_glycosites_with_glycan": 1,
    "total_reported_n_glycosites": 0,
    "total_reported_o_glycosites": 1,
    "total_n_glycosites": 0,
    "total_o_glycosites": 1,
    "reported_fully_resolved_glycans": 1,
    "reported_phosphosites": 0,
    "reported_mutagensis": 0,
    "reported_glycation": 0,
    "reported_snv": 0,
    "reported_interactions": 0,
    "missing_score": 0,
    "biomarker_type": "",
    "glycan_count": 1,
    "disease_count": 6,
    "glyco_site_count": 0,
    "binding_glycan_count": 0,
    "secondary_ac_list": "",
    "ec_number_list": [],
    "go_molecular_function": "GO:0017124 SH3 domain binding;GO:0050839 cell adhesion molecule binding;GO:0032794 GTPase activating protein binding",
    "go_cellular_component": "GO:0031594 neuromuscular junction;GO:0045171 intercellular bridge;GO:0032154 cleavage furrow;GO:0030496 midbody;GO:0098793 presynapse",
    "go_biological_process": "GO:0048749 compound eye development;GO:0043063 intercellular bridge organization;GO:0007015 actin filament organization;GO:0016477 cell migration;GO:0048260 positive regulation of receptor-mediated endocytosis",
    "synthesized_glycan_count": 0,
    "record_id": "A0A0B4KI34-1",
    "record_type": "protein",
    "filter_code": "0000000.0000111.100000.0000100000000000.01000.000"
}